HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.
about
Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutionsHematopoietic-stem-cell-based gene therapy for HIV diseaseDevelopment of Hematopoietic Stem Cell Based Gene Therapy for HIV-1 Infection: Considerations for Proof of Concept Studies and Translation to Standard Medical PracticeAccelerated disease progression and robust innate host response in aged SIVmac239-infected Chinese rhesus macaques is associated with enhanced immunosenescence.Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism.Immunity to HIV in Early LifeHuman T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriersThe colocalization potential of HIV-specific CD8+ and CD4+ T-cells is mediated by integrin β7 but not CCR6 and regulated by retinoic acid.Immune activation and HIV persistence: implications for curative approaches to HIV infection.Immunogenetics of small ruminant lentiviral infectionsHIV-associated chronic immune activation.HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscapeDissecting the dynamics of HIV-1 protein sequence diversity.Effect of human immunodeficiency virus infection on plasma bactericidal activity against Salmonella enterica serovar Typhimurium.HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathwaysIntestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infectionPlasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice.Report from the second cytomegalovirus and immunosenescence workshop.Mechanisms of immunosenescence: lessons from models of accelerated immune aging.P2X7 Receptor Inhibition Improves CD34 T-Cell Differentiation in HIV-Infected Immunological Nonresponders on c-ARTThirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.Intracellular expression of Tat alters mitochondrial functions in T cells: a potential mechanism to understand mitochondrial damage during HIV-1 replicationA Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammationMolecular and cellular mechanisms of Mycobacterium avium-induced thymic atrophy.Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment.CD8(+) lymphocytes suppress human immunodeficiency virus 1 replication by secreting type I interferons.Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaborationComposition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease.HIV controllers: a genetically determined or inducible phenotype?Unravelling the mechanisms of durable control of HIV-1.Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: clinical evaluation, classification, management prospects.Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View.Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy.Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers.Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals.Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune ActivationDeterminants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.
P2860
Q27021524-7FD3F390-2F75-4AB2-AF96-46E16F59205FQ27023434-12E357FA-F0C9-4AC0-984F-74A90693B620Q29036869-1F323C0A-F611-486E-9ACD-8048DD1FC6AFQ33671468-AF9EB013-1E0A-4C22-B6AD-C2AE03E64EA3Q33828349-4E9E0AA9-9A6C-4BF2-847F-42CE8F88A79CQ33889154-5193CB3C-5D98-4D54-8B0F-3199548EFF89Q34033051-8FC2DF65-0096-49D9-BEBE-80CAB12C2A7EQ34105919-A6496514-F718-4611-BE56-D70D6238859CQ34217360-2008E67F-7044-482D-95FD-F1BBD7939963Q34351320-68772506-440B-47AC-B3FE-1BE976F0C391Q34434913-2C4A0999-9FE4-494D-8FB1-AE7B08505CC4Q34653277-6A9E4C8A-9473-4AB6-B31E-7BDA2535AC84Q34671009-6AF6F592-65AE-439B-8068-CC9452366D84Q34672589-24047D14-5A5D-4B3D-ACEF-F3A441C6DA48Q34701418-08E06684-0041-4FD3-88D1-69CE85DFA5ADQ34889163-7AF90102-5044-4AF0-A1A3-F352FA58BDA3Q35078598-05B297BD-18D8-44C8-B762-2894834FD937Q35215887-02E16FFB-B74A-406F-90CA-C3BB291ABDB8Q35568719-0822AA44-8AA0-4DD3-93B2-A40F7530D64DQ35880403-5FE178D3-DB59-42D1-A5D4-BBB29AC6AFCBQ35991216-2EDBA547-89E0-44DB-9497-3B9CB6C3AD4DQ36010933-3D58C7D5-14F2-4D1B-912B-8B11D59B8C16Q36063046-91D6D087-628C-4203-98D1-732DD14EF7D3Q36144465-823CB10C-B701-444E-B581-C01D2DBDB212Q36145878-11AE7B84-8DF7-475B-AB82-B7A2131D65E1Q36670729-6726183E-53A7-4E5E-8805-2EB8DDEFA9C8Q37210830-7E73A0D5-6C2A-4AEA-A6E4-3475E6A08887Q37272275-D29B5C6C-5986-463F-A629-35DE49E96CFBQ37490654-C3481794-04CD-4073-AC12-FAC6FA3C8B4BQ37499490-8CA43332-1A2E-4DD8-9A97-791460563904Q38114915-74AD02FE-DB9F-4047-A573-82E68F312A06Q38116710-1FA4DB31-5154-41E0-8EE7-DE62EE0B80B2Q38619193-522DCB0C-C586-4155-8D40-A64A2CE1A2A9Q38918596-BDC24FB4-0B34-478B-9AF9-5126EBD12FCDQ38982997-0AC2B03B-60C4-453A-BA83-C7B149EBC8D1Q39278519-D49A6034-CAE8-4569-827E-189260FF3049Q39448439-526C4566-F812-4B3D-9EB1-99DAA055198FQ40266878-50FC864C-F800-432E-A0D7-31610E4CF525Q40625213-383F4CF8-4791-4F43-9F6D-CCDD5763D017Q40779840-1368BE1D-9F55-4550-83C5-386D1715E5BE
P2860
HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
HIV disease progression despit ...... h exhaustion of lymphopoiesis.
@en
type
label
HIV disease progression despit ...... h exhaustion of lymphopoiesis.
@en
prefLabel
HIV disease progression despit ...... h exhaustion of lymphopoiesis.
@en
P2093
P2860
P50
P1433
P1476
HIV disease progression despit ...... h exhaustion of lymphopoiesis.
@en
P2093
Amélie Guihot
Anne Simon
Anthony D Kelleher
Brigitte Autran
Claudine Duvivier
Faroudy Boufassa
Guislaine Carcelain
Hocine Ait-Mohand
John Zaunders
Laurence Meyer
P2860
P304
P356
10.1182/BLOOD-2011-01-331306
P407
P50
P577
2011-03-24T00:00:00Z